戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                     Familial incontinentia pigmenti (IP [MIM 308310]), or Bloch-Sulzb
2 h may result in two human genetic disorders, incontinentia pigmenti (IP) and hypohidrotic ectodermal
3 w-up of treated and untreated retinopathy in incontinentia pigmenti (IP) has not previously been docu
4                                              Incontinentia pigmenti (IP) is a genetic disease leading
5                                              Incontinentia pigmenti (IP) is an X-linked dominant diso
6                                              Incontinentia pigmenti (IP) is an X-linked dominant diso
7 e X-linked dominant and male-lethal disorder incontinentia pigmenti (IP) is caused by mutations in a
8 ritance pattern are very similar to those of incontinentia pigmenti (IP), a human genodermatosis, syn
9 e 131 female patients with X-linked dominant incontinentia pigmenti (IP), heterozygous for loss-of-fu
10                                              Incontinentia pigmenti (IP), or "Bloch-Sulzberger syndro
11 mma (NEMO) have been shown to cause familial incontinentia pigmenti (IP).
12 abnormalities associated with vision loss in incontinentia pigmenti (IP).
13 -kappaB signaling, cause the genetic disease incontinentia pigmenti (IP).
14 minant chondrodysplasia punctata (CDPX2) and incontinentia pigmenti (IP2), respectively, based on the
15                                              Incontinentia pigmenti (IP; MIM308300) is a severe, male
16                                              Incontinentia Pigmenti 2 (IP2) is an X-linked dominant d
17 and severe viral infections in patients with incontinentia pigmenti and heterozygous loss-of-function
18 d NEMO dysfunction in humans is the cause of incontinentia pigmenti and hypohidrotic ectodermal dyspl
19 linked, and mutations in this gene result in Incontinentia Pigmenti in human hemizygous females.
20 ructures are abrogated in cells derived from incontinentia pigmenti patients.
21 procal X;autosome translocations, a putative incontinentia pigmenti type 1 locus (IP1; MIM No.
22 of breast and ovarian cancer susceptibility, incontinentia pigmenti, and cylindromatosis.
23 is, mastocytosis, acropustulosis of infancy, incontinentia pigmenti, scabies, neonatal and congenital
24 nd in an individual with features of RTT and incontinentia pigmenti.
25  Cystic Fibrosis and one individual reported Incontinentia pigmenti.